Hvornår offentliggør Seattle Genetics, Inc. en resultatopgørelse?
Seattle Genetics, Inc. resultatopgørelse offentliggøres en gang i kvartalet, den seneste årsregnskab for Seattle Genetics, Inc. blev offentliggjort den 31/03/2021.
Hvad er fortjenesten fra aktierne i Seattle Genetics, Inc.?
Anslået indtjening pr. aktie i Seattle Genetics, Inc. var -0.67 $ i den sidste regnskabsrapport.
Hvornår vil Seattle Genetics, Inc. offentliggøre næste resultatopgørelse?
Den næste rapport om resultatopgørelsen Seattle Genetics, Inc. vil offentliggøres i Juni 2024.
Seattle Genetics, Inc. indtjening pr. Aktie i virksomheden - en af indikatorerne for virksomhedens indtægter fra størrelsen af dens værdi. Resultat pr. Aktie - beregnet værdi: den samlede fortjeneste for rapporteringsperioden divideres med antallet af eksisterende aktier. Det er tydeligt, at Seattle Genetics, Inc. indtjening pr. Aktie er et økonomisk kendetegn for en bestemt periode. Fortjeneste ved Seattle Genetics, Inc. - hele virksomhedens fortjeneste i rapporteringsperioden.
|
Fortjeneste Seattle Genetics, Inc.
Alle Seattle Genetics, Inc. overskud er en reference. Det er ikke så vigtigt for private aktionærer. En meget mere interessant indikator er indtjening pr. Aktie, der direkte påvirker mængden af udbytte pr. Datoen for resultatrapporten Seattle Genetics, Inc. er knyttet til lovgivningen i det land, hvor selskabet er registreret. Alle datoer for Seattle Genetics, Inc. overskudsrapporter vises i vores skema og vores tabel.
|
Kvartalsresultatet Seattle Genetics, Inc.
Resultat pr. Aktie Seattle Genetics, Inc. beregnes ved at dividere selskabets fortjeneste med antallet af dets aktier. Earnings per share of Seattle Genetics, Inc. is determined for a fixed financial period and corresponds to the outputs of the financial statements on the company's profit. Seattle Genetics, Inc. earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Quarterly profit Seattle Genetics, Inc. is the main type of financial statements among companies.
|
|
SGEN rapport dato
|
Indtjening pr. aktie
Resultat pr. aktie beregnes ved at dividere nettoindkomst (eller overskud) med antallet af aktier i selskabet.
|
Ændring i det sidste år %
|
|
31/03/2021 |
-0.67 USD |
- |
|
31/12/2020 |
0.9 USD |
+500% ↑ |
|
30/09/2020 |
3.5 USD |
-736.364% ↓ |
|
30/06/2020 |
-0.12 USD |
-75.51% ↓ |
|
31/12/2019 |
0.15 USD |
-5.811% ↓ |
|
30/09/2019 |
-0.55 USD |
-25% ↓ |
|
30/06/2019 |
-0.49 USD |
-2.145% ↓ |
|
31/03/2019 |
-0.08 USD |
-27.449% ↓ |
|
31/12/2018 |
-0.9 USD |
-1.23% ↓ |
|
30/09/2018 |
-0.42 USD |
-35.612% ↓ |
|
30/06/2018 |
0.47 USD |
-5.449% ↓ |
|
31/03/2018 |
-0.61 USD |
-1.652% ↓ |
|
31/12/2017 |
-0.41 USD |
-21.003% ↓ |
|
30/09/2017 |
-0.19 USD |
-30.961% ↓ |
|
30/06/2017 |
-0.39 USD |
-22.33% ↓ |
|
31/03/2017 |
-0.42 USD |
-77.0379% ↓ |
|
31/12/2016 |
-0.39 USD |
-41.0413% ↓ |
|
30/09/2016 |
-0.23 USD |
-30.629% ↓ |
|
30/06/2016 |
-0.23 USD |
-17.451% ↓ |
|
31/03/2016 |
-0.15 USD |
-50.102% ↓ |
|
31/12/2015 |
-0.18 USD |
-19.514% ↓ |
|
30/09/2015 |
-0.21 USD |
-15.643% ↓ |
|
30/06/2015 |
-0.38 USD |
-14.886% ↓ |
|
31/03/2015 |
-0.17 USD |
-9.274% ↓ |
|
31/12/2014 |
-0.22 USD |
-1.989% ↓ |
|
30/09/2014 |
-0.13 USD |
-7.267% ↓ |
|
30/06/2014 |
-0.14 USD |
-16.946% ↓ |
|
31/03/2014 |
-0.13 USD |
-4.426% ↓ |
|
31/12/2013 |
-0.13 USD |
-53.54% ↓ |
|
30/09/2013 |
-0.19 USD |
-30.819% ↓ |
|
30/06/2013 |
-0.06 USD |
-19.42% ↓ |
|
31/03/2013 |
-0.14 USD |
-40.398% ↓ |
|
31/12/2012 |
-0.09 USD |
-61.388% ↓ |
|
30/09/2012 |
-0.12 USD |
-67.0187% ↓ |
|
30/06/2012 |
-0.15 USD |
-61.69% ↓ |
|
31/03/2012 |
-0.11 USD |
-68.12% ↓ |
|
31/12/2011 |
-0.32 USD |
-22.932% ↓ |
|
30/09/2011 |
-0.35 USD |
-26.399% ↓ |
|
30/06/2011 |
-0.45 USD |
-94.892% ↓ |
|
31/03/2011 |
-0.3 USD |
-110.31% ↓ |
|
31/12/2010 |
-0.34 USD |
-40.79% ↓ |
|
30/09/2010 |
-0.34 USD |
-25.673% ↓ |
|
30/06/2010 |
-0.08 USD |
-93.104% ↓ |
|
31/03/2010 |
0.11 USD |
-113.103% ↓ |
|
31/12/2009 |
-0.12 USD |
-26.23% ↓ |
|
30/09/2009 |
-0.21 USD |
-5.787% ↓ |
|
30/06/2009 |
-0.26 USD |
-8.376% ↓ |
|
31/03/2009 |
-0.33 USD |
-36.945% ↓ |
|
31/12/2008 |
-0.38 USD |
-26.23% ↓ |
|
30/09/2008 |
-0.27 USD |
-43.285% ↓ |
|
30/06/2008 |
-0.2 USD |
-38.169% ↓ |
|
31/03/2008 |
-0.22 USD |
-5.939% ↓ |
|
31/12/2007 |
-0.22 USD |
-8.889% ↓ |
|
30/09/2007 |
-0.22 USD |
-23.75% ↓ |
|
30/06/2007 |
-0.18 USD |
-14.432% ↓ |
|
31/03/2007 |
-0.16 USD |
-2.273% ↓ |
|
31/12/2006 |
-0.2 USD |
-16.259% ↓ |
|
30/09/2006 |
-0.17 USD |
-16.667% ↓ |
|
30/06/2006 |
-0.17 USD |
-11.111% ↓ |
|
31/03/2006 |
-0.21 USD |
-28.455% ↓ |
|
31/12/2005 |
-0.17 USD |
-30.87% ↓ |
|
30/09/2005 |
-0.15 USD |
-37.119% ↓ |
|
30/06/2005 |
-0.2 USD |
-75.361% ↓ |
|
31/03/2005 |
-0.18 USD |
-25.476% ↓ |
|
31/12/2004 |
-0.25 USD |
-21.476% ↓ |
|
30/09/2004 |
-0.4 USD |
-43.669% ↓ |
|
30/06/2004 |
-0.89 USD |
-77.186% ↓ |
|
31/03/2004 |
-0.24 USD |
-5.985% ↓ |
|
31/12/2003 |
-0.18 USD |
-4.878% ↓ |
|
30/09/2003 |
-0.17 USD |
-14% ↓ |
|
30/06/2003 |
-0.18 USD |
-16.667% ↓ |
|
31/03/2003 |
-0.2 USD |
-30.357% ↓ |
|
31/12/2002 |
-0.19 USD |
- |
|
30/09/2002 |
-0.17 USD |
- |
|
30/06/2002 |
-0.21 USD |
- |
|
31/03/2002 |
-0.2 USD |
- |
Seattle Genetics, Inc. quarterly earnings per share are the estimated profitability of the company. They have intermediate significance among analysts. But annual earnings per share are of primary importance. Last quarterly profit Seattle Genetics, Inc. today is the officially declared profit for the last reference quarter. Change in profit Seattle Genetics, Inc. for the year is a calculated value for additional information that shows the change in percentage of profit with the same interval of the last year. A change in Seattle Genetics, Inc. quarterly profit compared to last year may be significant for companies with a seasonal business. But the main indicator of the company's profitability is the annual change in profit.
The change in profit is shown as a percentage. Overskudshistorikken for Seattle Genetics, Inc. for tidligere år fremgår af vores tabel "Kvartalsvis overskud". Seattle Genetics, Inc. kvartalsvise indtjeningshistorik er tilgængelig online for hvert år og kvartal i de sidste ti år. Virksomhedens Seattle Genetics, Inc. overskudsdatabase for tidligere år er samlet fra åbne kilder.
|
